Two Coronary "Orphan" Diseases in Search of Clinical Consideration: Coronary Syndromes X and Y

Cardiovascular Therapeutics

Volumn 30, Issue 2, 2012, Pages

  Gori, Tommaso ^a   Fineschi, Massimo ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Ischemia; Microvasculature; Slow flow

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MIFEBRADIL; NITRATE; NITRIC ACID DERIVATIVE; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE;

ADULT; AGED; ANGIOCARDIOGRAPHY; BICYCLE ERGOMETRY; CARDIOMYOPATHY; CASE REPORT; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SPASM; CORONARY FLOW RESERVE; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; MALE; MYOCARDITIS; NEUROMODULATION; NOCICEPTION; PATHOPHYSIOLOGY; PRECORDIAL PAIN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SPINAL CORD STIMULATION; ST SEGMENT DEPRESSION; STABLE ANGINA PECTORIS; SYNDROME X; SYNDROME Y; TREADMILL; VALVULAR HEART DISEASE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA PECTORIS; CHEST PAIN; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; MALE; MICROVASCULAR ANGINA; MYOCARDIAL ISCHEMIA; PAPAVERINE; PROGNOSIS; RARE DISEASES; TREATMENT OUTCOME; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 84858325119     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2010.00232.x     Document Type: Review

References (79)

1. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation 1996;93:879-888.
2. Crea F, Lanza GA. Angina pectoris and normal coronary arteries: Cardiac syndrome X. Heart 2004;90:457-463.
3. Melikian N, De Bruyne B, Fearon WF, MacCarthy PA. The pathophysiology and clinical course of the normal coronary angina syndrome (cardiac syndrome X). Prog Cardiovasc Dis 2008;50:294-310.
4. Yang EH, Lerman A. Management of the patient with chest pain and a normal coronary angiogram. Cardiol Clin 2005;23:559-568, viii.
5. Fineschi M, Bravi A, Gori T. The "slow coronary flow" phenomenon: Evidence of preserved coronary flow reserve despite increased resting microvascular resistances. Int J Cardiol 2008;127:358-361.
6. Fearon WF, Balsam LB, Farouque HM, et al. Novel index for invasively assessing the coronary microcirculation. Circulation 2003;107:3129-3132.
7. Ng MK, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation: Superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve. Circulation 2006;113:2054-2061.
8. Bugiardini R, Bairey Merz CN. Angina with "normal" coronary arteries: A changing philosophy. JAMA 2005;293:477-484.
9. Pijls NH, Van Gelder B, Van der, V, et al. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995;92:3183-3193.
10. Kaski JC. Overview of gender aspects of cardiac syndrome X. Cardiovasc Res 2002;53:620-626.
11. Beltrame JF. Advances in understanding the mechanisms of angina pectoris in cardiac syndrome X. Eur Heart J 2005;26:946-948.
12. Kaski JC, Elliott PM. Angina pectoris and normal coronary arteriograms: Clinical presentation and hemodynamic characteristics. Am J Cardiol 1995;76:35D-42D.
13. Kaski JC, Rosano GM, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson PA. Cardiac syndrome X: Clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 1995;25:807-814.
14. Gould KL, Lipscomb K, Calvert C. Compensatory changes of the distal coronary vascular bed during progressive coronary constriction. Circulation 1975;51:1085-1094.
15. Lipscomb K, Gould KL. Mechanism of the effect of coronary artery stenosis on coronary flow in the dog. Am Heart J 1975;89:60-67.
16. Lanzarini L, Previtali M, Fetiveau R, Poli A. Results of dobutamine stress echocardiography in patients with syndrome X. Int J Card Imaging 1994;10:145-148.
17. Maseri A, Crea F, Kaski JC, Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol 1991;17:499-506.
18. Asbury EA, Collins P. Cardiac syndrome X. Int J Clin Pract 2005;59:1063-1069.
19. Arbogast R, Bourassa MG. Myocardial function during atrial pacing in patients with angina pectoris and normal coronary arteriograms. Comparison with patients having significant coronary artery disease. Am J Cardiol 1973;32:257-263.
20. Kemp HG Jr. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol 1973;32:375-376.
21. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993;328:1659-1664.
22. Quyyumi AA, Cannon RO III, Panza JA, Diodati JG, Epstein SE. Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation 1992;86:1864-1871.
23. Cannon RO III, Epstein SE. "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988;61:1338-1343.
24. Cannon RO III, Schenke WH, Quyyumi A, Bonow RO, Epstein SE. Comparison of exercise testing with studies of coronary flow reserve in patients with microvascular angina. Circulation 1991;83:III77-III81.
25. Greenberg MA, Grose RM, Neuburger N, Silverman R, Strain JE, Cohen MV. Impaired coronary vasodilator responsiveness as a cause of lactate production during pacing-induced ischemia in patients with angina pectoris and normal coronary arteries. J Am Coll Cardiol 1987;9:743-751.
26. Crake T, Canepa-Anson R, Shapiro L, Poole-Wilson PA. Continuous recording of coronary sinus oxygen saturation during atrial pacing in patients with coronary artery disease or with syndrome X. Br Heart J 1988;59:31-38.
27. Panting JR, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-1953.
28. Meeder JG, Blanksma PK, Crijns HJ, et al. Mechanisms of angina pectoris in syndrome X assessed by myocardial perfusion dynamics and heart rate variability. Eur Heart J 1995;16:1571-1577.
29. Lanza GA, Buffon A, Sestito A, et al. Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J Am Coll Cardiol 2008;51:466-472.
30. Opherk D, Zebe H, Weihe E, et al. Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms. Circulation 1981;63:817-825.
31. Gaspardone A, Ferri C, Crea F, et al. Enhanced activity of sodium-lithium countertransport in patients with cardiac syndrome X: A potential link between cardiac and metabolic syndrome X. J Am Coll Cardiol 1998;32:2031-2034.
32. Salomone OA, Elliott PM, Calvino R, Holt D, Kaski JC. Plasma immunoreactive endothelin concentration correlates with severity of coronary artery disease in patients with stable angina pectoris and normal ventricular function. J Am Coll Cardiol 1996;28:14-19.
33. Rosen SD, Paulesu E, Nihoyannopoulos P, et al. Silent ischemia as a central problem: Regional brain activation compared in silent and painful myocardial ischemia. Ann Intern Med 1996;124:939-949.
34. Lanza GA, Sestito A, Sgueglia GA, et al. Effect of spinal cord stimulation on spontaneous and stress-induced angina and 'ischemia-like' ST-segment depression in patients with cardiac syndrome X. Eur Heart J 2005;26:983-989.
35. Kaski JC, Aldama G, Cosin-Sales J. Cardiac syndrome X. Diagnosis, pathogenesis and management. Am J Cardiovasc Drugs 2004;4:179-194.
36. Kaski JC, Valenzuela Garcia LF. Therapeutic options for the management of patients with cardiac syndrome X. Eur Heart J 2001;22:283-293.
37. Kaski JC. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation 2004;109:568-572.
38. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries: A new angiographic finding. Am Heart J 1972;84:66-71.
39. Goel PK, Gupta SK, Agarwal A, Kapoor A. Slow coronary flow: A distinct angiographic subgroup in syndrome X. Angiology 2001;52:507-514.
40. Leone MC, Gori T, Fineschi M. The coronary slow flow phenomenon: A new cardiac "Y" syndrome? Clin Hemorheol Microcirc 2008;39:185-190.
41. Li JJ, Wu YJ, Qin XW. Should slow coronary flow be considered as a coronary syndrome? Med Hypotheses 2006;66:953-956.
42. Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon: A new coronary microvascular disorder. Cardiology 2002;97:197-202.
43. Beltrame JF, Limaye SB, Wuttke RD, Horowitz JD. Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J 2003;146:84-90.
44. Fineschi M, Gori T. Coronary slow flow: Description of a new "cardiac Y" syndrome. Int J Cardiol 2009;137:308-310.
45. Mangieri E, Macchiarelli G, Ciavolella M, et al. Slow coronary flow: Clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 1996;37:375-381.
46. Galiuto L, Crea F. No-reflow: A heterogeneous clinical phenomenon with multiple therapeutic strategies. Curr Pharm Des 2006;12:3807-3815.
47. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-1508.
48. Fischell TA. Pharmaceutical interventions for the management of no-reflow. J Invasive Cardiol 2008;20:374-379.
49. Demirkol MO, Yaymaci B, Mutlu B. Dipyridamole myocardial perfusion single photon emission computed tomography in patients with slow coronary flow. Coron Artery Dis 2002;13:223-229.
50. Cesar LA, Ramires JA, Serrano Junior CV, et al. Slow coronary run-off in patients with angina pectoris: Clinical significance and thallium-201 scintigraphic study. Braz J Med Biol Res 1996;29:605-613.
51. Saya S, Hennebry TA, Lozano P, Lazzara R, Schechter E. Coronary slow flow phenomenon and risk for sudden cardiac death due to ventricular arrhythmias: A case report and review of literature. Clin Cardiol 2008;31:352-355.
52. Singh S, Kothari SS, Bahl VK. Coronary slow flow phenomenon: An angiographic curiosity. Indian Heart J 2004;56:613-617.
53. Diver DJ, Bier JD, Ferreira PE, et al. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol 1994;74:531-537.
54. Mangieri E, Tanzilli G, De Vincentis G, et al. Slow coronary flow and stress myocardial perfusion imaging. Different patterns in acute patients. J Cardiovasc Med (Hagerstown) 2006;7:322-327.
55. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986;74:964-972.
56. Meiselman HJ, Baskurt OK. Hemorheology and hemodynamics: Dove andare? Clin Hemorheol Microcirc 2006;35:37-43.
57. Forconi S, Gori T. The evolution of the meaning of blood hyperviscosity in cardiovascular physiopathology: Should we reinterpret Poiseuille? Clin Hemorheol Microcirc 2009;42:1-6.
58. Rossi M, Carpi A, Di Maria C, Galetta F, Santoro G. Absent post-ischemic increase of blood flowmotion in the cutaneous microcirculation of healthy chronic cigarette smokers. Clin Hemorheol Microcirc 2007;36:163-171.
59. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest 2007;131:1557-1566.
60. Fam WM, McGregor M. Effect of nitroglycerin and dipyridamole on regional coronary resistance. Circ Res 1968;22:649-659.
61. Kurtoglu N, Akcay A, Dindar I. Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow. Am J Cardiol 2001;87:777-779, A8.
62. Lee BK, Durairaj A, Mehra A, Wenby RB, Meiselman HJ, Alexy T. Hemorheological abnormalities in stable angina and acute coronary syndromes. Clin Hemorheol Microcirc 2008;39:43-51.
63. Binak E, Gunduz H, Sahin M, Kurtoglu N, Dindar I. The relation between impaired glucose tolerance and slow coronary flow. Int J Cardiol 2006;111:142-146.
64. Selcuk H, Selcuk MT, Temizhan A, et al. Decreased plasma concentrations of adiponectin in patients with slow coronary flow. Heart Vessels 2009;24:1-7.
65. Li JJ, Qin XW, Li ZC, et al. Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow. Clin Chim Acta 2007;385:43-47.
66. Barutcu I, Sezgin AT, Sezgin N, et al. Increased high sensitive CRP level and its significance in pathogenesis of slow coronary flow. Angiology 2007;58:401-407.
67. Li JJ, Xu B, Li ZC, Qian J, Wei BQ. Is slow coronary flow associated with inflammation? Med Hypotheses 2006;66:504-508.
68. Turhan H, Saydam GS, Erbay AR, et al. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow. Int J Cardiol 2006;108:224-230.
69. Sezgin AT, Sigirci A, Barutcu I, et al. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 2003;14:155-161.
70. Muxel S, Fineschi M, Hauser ER, Gori T. Coronary slow flow or syndrome Y: Dysfunction at rest, preserved reactivity of the peripheral endothelium. Int J Cardiol 2010. PMID: 20488564.
71. Sharman JE, Moir S, Kostner KM, Haluska B, Marwick TH. Patients with coronary slow flow phenomenon demonstrate normal myocardial blood flow and arterial wave reflection between acute episodes. Int J Cardiol 2009;131:321-325.
72. Beltrame JF, Turner SP, Horowitz JD. Persistence of the coronary slow flow phenomenon. Am J Cardiol 2001;88:938.
73. Kapoor A, Goel PK, Gupta S. Slow coronary flow: A cause for angina with ST segment elevation and normal coronary arteries. A case report. Int J Cardiol 1998;67:257-261.
74. Atak R, Turhan H, Sezgin AT, et al. Effects of slow coronary artery flow on QT interval duration and dispersion. Ann Noninvasive Electrocardiol 2003;8:107-111.
75. Beltrame JF, Turner SP, Leslie SL, Solomon P, Freedman SB, Horowitz JD. The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon. J Am Coll Cardiol 2004;44:57-62.
76. Cakmak M, Tanriverdi H, Cakmak N, Evrengul H, Cetemen S, Kuru O. Simvastatin may improve myocardial perfusion abnormality in slow coronary flow. Cardiology 2008;110:39-44.
77. Caliskan M, Erdogan D, Gullu H, et al. Effects of atorvastatin on coronary flow reserve in patients with slow coronary flow. Clin Cardiol 2007;30:475-479.
78. Li JJ, Zheng X, Li J. Statins may be beneficial for patients with slow coronary flow syndrome due to its anti-inflammatory property. Med Hypotheses 2007;69:333-337.
79. Fineschi M, Sinicropi G, Gori T. Images in cardiology. The coronary "echo-stenotic" reflex. Heart 2006;92:300.